Shamir Optical Industry (SHMR)

[swampboots]

SHMR 8.54 .8 straight days of new HOD's.eom

[swampboots]

OT:
COR – CX717 completed toxicology data: Jan 2007. (FDA clinical hold was lifted 10/9/06.) Go/no-go decision on CX-717: Feb/Mar 2007.

[Aiming4]

You're welcome, I should have joined you! Congrats on your gains, I'm up a little on some COR I bought yesterday... Aiming4.

[swampboots]

Thanks for reminder 8.47, is near 10% rise off bottom and think it broke the death spiral.

[swampboots]

SHMR 8.40 nice slow move and stuanch of dive eom.

[swampboots]

SHMR 8.17 ok a start.

[swampboots]

I did today( SHMR 7.68)!!! thanks I will buy more cheaper if it goes that way and I hope to fill more and more in that direction.

I took a bath in EVSNF, worst loss in many years so be warned about my track record although my postings on "Jan Effect Board" has done well since OCT (you can study for next year agains each posted buy and historical prices in real time).

[Aiming4]

Swampboots - did you end up accumulating SHMR and are you still holding?

I see it's at a 1 year low right now, perhaps a very nice entry point?

Thanks for your thoughts... Aiming4.

[midastouch017]

Wed: Through a lens brightly
Shamir Optical Industries may well a worthwhile buy, but don’t rush.

Shlomo Greenberg

Shamir Optical Industries Ltd. (Nasdaq: SHMR; TASE: SHMR) has not delivered the goods for investors. The company was floated less than two years ago, in an IPO underwritten by William Blair & Co., at $14. Its share price peaked at $18 two months later, and has been falling ever since.
Last week, Shamir Optical published its results for the first quarter of 2006, which were a pleasant surprise. The company develops, manufactures, and markets spectacles lens that are considered to be top quality and state-of-the-art technology. The financial report showed that the company beat analysts’ forecasts.

CIBC World Markets analysts consider Shamir Optical’s first quarter to be “a good start”. First, they were very pleased by the increase in sales worldwide. The establishment of a US marketing company was shown to be a great success, and the analysts believe that the company has begun to consolidate its markets in France and Turkey. CIBC raised its 2006 sales forecast for the company to $94.8 million, while keeping its earning per share forecast at $0.61. CIBC predicts that the company’s sales will grow 12% in 2007, and that its earnings per share will rise by 20% to $0.73.

CIBC gives Shamir Optical a “Sector Outperform” recommendation, i.e. a “Buy” recommendation, because it thinks that the company’s performance will be better than the industry average. The company’s competitors, such as Germany’s Carl Zeiss AG and Bausch & Lomb Inc. (NYSE:BOL) of the US, have much more experience in the sector, , which is why Shamir Optical focuses on specialized lenses.

It is important for an investor in Shamir Optical’s shares to understand precisely what he or she is investing in. An observer of the company and its development cannot but be impressed by its professionalism and thoroughness. The company was founded in 1972 to manufacture bifocal lenses. In 1997, the company, which is based on manufacturing excellence and investment in new technologies, entered into partnership with Eyal Optical Industries Ltd., which was later merged into Shamir Optical. Eyal Optical is the division that develops technologies, and makes it possible for the company to maintain its technological leadership in lens production.

The man who founded and still runs the company is president and CEO Giora Ben-Zeev, a member of Kibbutz Shamir. Although he is listed as a member of the kibbutz, I am sure that in addition to membership, he has two other advantages: managerial skills (after all, founding and running this dream company is no simple matter, certainly not for a mere “kibbutz member”). And if he is not a graduate of the engineering faculty at Technion - Israel Institute of Technology, or has an MBA from some other university, he must be a yekke (of German descent), otherwise I cannot explain this phenomenon.

Is it worthwhile buying Shamir Optical at $9.60? If the first quarter results are a sign of things to come, then definitely, but it’s more important to repeat my mantra: “Put limits in place, and don’t rush. These are days for flight, not fight.”

Published by Globes [online], Israel business news - www.globes.co.il - on May 24, 2006

http://www.globes.co.il/serveen/globes/docview.asp?did=1000095582&fid=1052

Dubi

[swampboots]

SHMR Guidance is lowered by about 10% but share price reflects these considerations:
"Shamir Optical Industry Guides Below Estimates
Tuesday, February 28, 2006 4:14:19 PM ET
View: Complete Article | Historical Guidance
Shamir Optical Industry (SHMR) said it expects 2006 non-GAAP net income of $10.3 million to $11.2 million, or earnings of approximately $0.62 to $0.68 per share on revenue of $91.0 million to $96.0 million. The current consensus earnings estimate is $0.73 per share on revenue of $99.5 million for the year ending December 31, 2006."


I wish to accumulate near $9 as I think build out will soon exceed estimates and currency fluctuations favor the Euro, besides the sector is excellent for defensive positioning
should there be a general economic decline.

[swampboots]

SHMR 9.30 I will explain later but I am accumulating at these prices.

[midastouch017]

Shamir Optical falls short of forecasts with 1.5% revenue growth in Q4

01.3.06 | 10:40 By Shirley Yom Tov

As the year 2005 progressed, revenue growth at Shamir Optical Industry (Nasdaq: SHMR) did nothing but contract. First-quarter 2005 growth had been more than 30% but by the time the fourth quarter arrived, growth had contracted to 1.5%.

Shamir Optical, a Kibbutz Shamir company, disappointed the Street yet again, this time missing forecasts with fourth-quarter 2005 revenues of $20.1 million, versus expectations of $22.4 million. The company explained that it had to defer $0.9 million revenues that had been included in its guidance. The missing income will be recognized in the first quarter of 2006.

Also, the weakness of the euro against the dollar during the relevant period impaired its results, explained Shamir, which makes complex lenses for the seeing-impaired.

In the parallel quarter of 2004,.revenues had been $19.8 million.

Despite the slowing growth, gross profit continued to increase, rising to $11.4 million in the fourth quarter of 2005, or 56.8% of revenues, compared to $11.2 million, or 56.3% of revenues for the same period of 2004.

As in the third quarter, operating costs ran close to a million dollars and operating profit therefore shrank to 13%, from 16.5% in the parallel quarter of 2004.

For the fourth quarter of 2005, operating income was $2.6 million, down 20.4% from operating income of $3.3 million for the same period last year.

During the quarter, Shamir established a new operation in France and expanded its marketing and distribution platform in Turkey. These activities resulted in an operational loss of $0.8 million, it explained.

Net income for the quarter was $2.1 million or $0.13 per diluted share, an increase of 10.6% compared to pro forma net income of $1.9 million for the comparable period in 2004.

For the year 2005, revenues were $80.4 million, up almost 13% compared to revenues of $71.3 million for 2004. Shamir grossed $44.3 million or 55.2% of revenues, up 17.1% against the year before.

It netted $8.1 million or 52 cents per share in 2005, up 14.1% against $7.1 million in 2004.

At year-end 2005, Shamir had cash and cash equivalents including short-term investments of $42 million.

Shamir Optical also published its guidance for the year 2006, and it's a let down for investors. While Street players had been looking at $99 million, Shamir counseled them to lower their sights to $91-96 million. It expects to earn $9.1 million to $10 million net, instead of $11.9 million.

http://www.haaretz.com/hasen/spages/688974.html

Dubi

[midastouch017]

A quick read does not leave me too impressed.

Dubi

[midastouch017]

Shamir Optical Industry Ltd Reports Fourth Quarter and Year-End 2005 Results

Tuesday February 28, 4:15 pm ET

Fourth Quarter Revenues of $20.1 Million
Fourth Quarter Net Income of $2.1 Million, or $0.13 Per Diluted Share

KIBBUTZ SHAMIR, Israel, Feb. 28 /PRNewswire-FirstCall/ --

Shamir Optical Industry Ltd (Nasdaq: SHMR - News), a leading provider of innovative products and technology to the progressive ophthalmic lens market, today announced unaudited financial results for the fourth quarter and year ended December 31, 2005.

For the fourth quarter of 2005, revenues were $20.1 million compared to revenues of $19.8 million for the fourth quarter of 2004. Revenues were negatively affected by a shift in the recognition of a $0.9 million sale of products, which was included in the Company's forecast for the fourth quarter. Although the order was shipped during the fourth quarter, these revenues will be recognized in 2006. Revenues during the quarter were also negatively affected by the decrease of the Euro compared to the Dollar.

Gross profit for the quarter was $11.4 million, or 56.8% of revenues, compared to gross profit of $11.2 million, or 56.3% of revenues for the same period last year.

For the fourth quarter of 2005, operating income was $2.6 million, or 13.0% of revenues, a decrease of 20.4% from operating income of $3.3 million, or 16.5% of revenues for the same period last year. During the quarter, Shamir established a new operation in France and expanded its marketing and distribution platform in Turkey. These activities resulted in an operational loss of $0.8 million.

Net income for the quarter was $2.1 million or $0.13 per diluted share, an increase of 10.6% compared to pro forma net income of $1.9 million for the comparable period in 2004.

Excluding the effects of non-cash stock-based compensation expenses for the fourth quarter of 2005, operating income was $2.7 million, or 13.6% of revenues. This was a decrease of 17.7% from operating income of $3.3 million for the same period last year.

Excluding the effects of non-cash stock-based compensation expenses, net income for the quarter was $2.3 million, compared to $2.0 million for the comparable period in 2004. The reconciliation of GAAP net income to adjusted net income is set forth below in this release.

For the year ended December 31, 2005, revenues were $80.4 million, an increase of 12.8% compared to revenues of $71.3 million for the same period of 2004. Gross profit for the year was $44.3 million, or 55.2% of revenues, an increase of 17.1% from a gross profit of $37.9 million, or 53.1% of revenues for the same period last year.

For the year ended December 31, 2005, operating income was $12.1 million, or 15.1% of revenues, a decrease of 3.4% from operating income of $12.5 million, or 17.6% of revenues for the same period last year. Net income for the year was $8.1 million or $0.51 per diluted share, an increase of 14.1% compared to pro forma net income of $7.1 million for the comparable period in 2004.

Excluding the effects of non-cash stock-based compensation expenses, for the year ended December 31, 2005, operating income was $12.7 million, or 15.8% of revenues, compared to operating income of $12.6 million, or 17.7 % of revenues, for the same period last year.

Excluding the effects of non-cash stock-based compensation expenses and non-cash tax effect of changes in status from a non-taxable to a taxable entity, net income for the year was $9.0 million, or 11.2% of revenues. This was an increase of 25.5% from net income of $7.2 million for the same period last year.

The reconciliation of GAAP operating income and net income to adjusted operating income and adjusted net income is set forth below in this release.

As of December 31, 2005, the Company had cash and cash equivalents including short-term investments of $42.0 million.

Commenting on its fourth quarter results, Giora Ben-Zeev, Chief Executive Officer of Shamir Optical, said, "2005 was an exciting and gratifying year for Shamir. In March, we listed our shares on NASDAQ and throughout the year we made strategic investments in our operations and sales and marketing platform, aimed at worldwide expansion and positioning Shamir for future growth."

"Our results this quarter and last year demonstrated year-over-year growth on both the top and bottom line. We believe these results are a good indication of our ability to deliver quality optical lenses and innovative technology, which combined with our strengthening competitive position, contributed to our solid results."

Mr. Ben-Zeev added, "In 2005, we established a presence in Turkey and started to penetrate this growing market. In France, we established a sales and distribution platform to market finished spectacle lenses to major optical chains and retail outlets. We believe the French market offers Shamir significant opportunity."

"In South Africa we purchased 51% of our South African distributor in order to expand our operations in this market. In early 2006, we formed a joint venture in Israel with a leading marketing company of branded frames and contact lenses, to market our lenses to the Israeli ophthalmic market, including major optical chains and retail outlets. To support the local market's demand and the production needs in Europe, we will soon establish a lab in Israel, based on the Free-Form technology."

"I believe the actions we took during 2005 to expand and support the growth of our UK laboratory have been effective, and as a result we are beginning to gain traction in the UK market. Additionally, our U.S. subsidiary reaffirmed its position in the United States as evidenced by its increased revenues."

Mr. Ben-Zeev concluded, "In 2006, we remain committed to delivering world-class products and increasing Shamir's presence in both new and existing markets as we continue to develop a solid platform from which we can build on our success."


FY 2006 Guidance (in millions):

Revenues $91 - $96
GAAP Earnings $ 9.1 - $10
Non-GAAP Earnings $10.3 - $11.2

Conference Call:
Shamir Optical has scheduled a conference call for 9:00 a.m. EST tomorrow, Wednesday, March 1, 2006, to discuss fourth quarter and year-end results. To participate in the call, please dial 800-247-9979 (U.S. and Canada), or 973-409-9254 (International). For those unable to participate there will be replay available from 12:00 p.m. EST on March 1, 2006 through 11:59 p.m. EST, March 8, 2006. To listen to the replay, please call: 877-519-4471 (U.S. and Canada), 973-341-3080 (International). The ID code for the replay is 7038902.

http://biz.yahoo.com/prnews/060228/nytu141.html?.v=46

Dubi

[midastouch017]

Analyst Opinion Get Analyst Opinion for:

RECOMMENDATION SUMMARY*
Mean Recommendation (this week): 1.3
Mean Recommendation (last week): 1.3
Change: 0.0
Industry Mean:
Sector Mean:
S&P 500 Mean: 2.46

* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Compare to Industry
PRICE TARGET SUMMARY
Mean Target: 17.00
Median Target: 17.00
High Target: 19.00
Low Target: 15.00
No. of Brokers: 2

http://finance.yahoo.com/q/ao?s=SHMR

Dubi